BerGenBio | Sustainability Performance
A biotechnology company focusing on cancer treatment development, it works on therapies targeting aggressive forms of cancer and related biomarkers.
2007
Norway
11 - 50 employees
Biotechnology
$1M - 10M in revenue
Not profitable
Sustainability Ranking & Industry Benchmark
#4788
Overall#75
in Norway#61
in BiotechnologySustainability Maturity
Sustainability Intent
Overview
Environmental
Digital emissionsEnergy consumptionGovernance
TargetsESG scores and ExclusionsFinancial Data
Business performanceCapital & innovationAnalyst projections
Renewable energy
Critical
Revenue
Renewable electricity
Reveal data for 1 credit
34%2021
Industry rank: 16 out of 251
Total electricity consumption
and % renewables
(MWh, % of consumption)
Industry rank: 16 out of 251
Total electricity
Share of renewable electricity
Industry benchmark
Digital Emissions
CO2e per visit (g)
Industry benchmark
B/M 0.26 g
B
Environmental ScoreScore B
Green HostingYes
Controversy level
Powered by illuminem
Revenue
EBITDA
Operating margin
Revenue & EBITDA
$0.0FY2022 revenue
Total Annual
Revenue & EBITDA
($ B)
Annual revenue
EBITDA
3 year change
Margin trends
Margin as % of revenue
Gross margin
Operating margin
Net margin
Powered by illuminem
Free cashflow
Capex
Debt/equity ratio
Return on invested capital
-112.0%FY2026
Return on invested capital (ROIC)
Industry benchmark
Powered by illuminem
Analyst revenue estimates & actuals
Analyst consensus vs actuals
($ B)
Actual revenue
Consensus estimates
Estimate only
0.0
2028Powered by illuminem
Sustainability targets and commitments
| Target | Year | Value | Scope | Baseline |
|---|
Progress against targets
Overall score
0
Environment
0
Social
0
Governance
0
Exclusion screening
Adult content
Not available
Alcoholic
Not available
Animal testing
Not available
Firearms
Not available
Tobacco
Not available
Gambling
Not available
Nuclear
Not available
